MultiGEN Diagnostics Overview

  • Founded
  • 2006
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

MultiGEN Diagnostics General Information


Developer of multiplexed assays based on a novel modification of the 'Gold Standard' Sanger sequencing method. The company provide accurate and comprehensive bio-informatics for molecular diagnostics, drug development and personalized medicine.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Rockhill, PA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MultiGEN Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 07-Apr-2014 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view MultiGEN Diagnostics’s complete valuation and funding history, request access »

MultiGEN Diagnostics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vencore Capital Venture Capital Minority 000 0000 000000 0
To view MultiGEN Diagnostics’s complete investors history, request access »